Key Documents

View All Documentation

59452

(S)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate

Name: (<I>S</I>)-2,2-Dimethyl-1,3-dioxolane-4-methanol p-toluenesulfonate
Brand: SIAL

purum, ≥99.0% (sum of enantiomers, GC)

Synonym(s):

2,3-Isopropylidene-sn-glycerol 1-tosylate, L-α,β-Isopropylideneglycerol-γ-tosylate

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₃H₁₈O₅S

CAS Number:

23735-43-5

Molecular Weight:

286.34

PubChem Substance ID:

329758669

UNSPSC Code:

12352005

Beilstein/REAXYS Number:

89799

MDL number:

MFCD00063234

Assay:

≥99.0% (sum of enantiomers, GC)

Form:

solid

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

purum

assay

≥99.0% (sum of enantiomers, GC)

form

solid

optical activity

[α]20/D +7.5±0.5°, c = 2% in DMF

mp

29-31 °C

storage temp.

2-8°C

SMILES string

Cc1ccc(cc1)S(=O)(=O)OC[C@@H]2COC(C)(C)O2

InChI

1S/C13H18O5S/c1-10-4-6-12(7-5-10)19(14,15)17-9-11-8-16-13(2,3)18-11/h4-7,11H,8-9H2,1-3H3/t11-/m0/s1

InChI key

SRKDUHUULIWXFT-NSHDSACASA-N

Description

Other Notes

Chiral building block, e.g. synthesis of GABOB

pictograms

GHS07

signalword

Warning

hcodes

H315,H319,H335

pcodes

P261 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

235.4 °F - closed cup

flash_point_c

113 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Line S Tarpgaard et al.

Oncotarget, 7(37), 59441-59457 (2016-08-11)

It is now widely accepted that therapeutic antibodies targeting epidermal growth factor receptor (EGFR) can have efficacy in KRAS wild-type advanced colorectal cancer (CRC) patients. What remains to be ascertained is whether a subgroup of KRAS-mutated CRC patients might not

M.E. Jung et al.

Journal of the American Chemical Society, 102, 6304-6304 (1980)